Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Bile modulates secretion of incretins and insulin: a study on human extrahepatic cholestasis.

Mezza T, Moffa S, Ferraro PM, Quero G, Capece U, Carfì A, Cefalo CMA, Cinti F, Sorice GP, Impronta F, Mari A, Pontecorvi A, Alfieri S, Holst JJ, Giaccari A.

J Clin Endocrinol Metab. 2019 Mar 15. pii: jc.2018-02804. doi: 10.1210/jc.2018-02804. [Epub ahead of print]

PMID:
30874733
2.

A preliminary survey of practice patterns across several European kidney stone centers and a call for action in developing shared practice.

Ferraro PM, Arrabal-Polo MÁ, Capasso G, Croppi E, Cupisti A, Ernandez T, Fuster DG, Galan JA, Grases F, Hoorn EJ, Knauf F, Letavernier E, Mohebbi N, Moochhala S, Petkova K, Pozdzik A, Sayer J, Seitz C, Strazzullo P, Trinchieri A, Vezzoli G, Vitale C, Vogt L, Unwin RJ, Bonny O, Gambaro G.

Urolithiasis. 2019 Mar 8. doi: 10.1007/s00240-019-01119-z. [Epub ahead of print]

PMID:
30848320
3.

Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms.

Gambaro G, Zaza G, Citterio F, Naticchia A, Ferraro PM.

Urolithiasis. 2019 Feb;47(1):115-123. doi: 10.1007/s00240-018-1092-4. Epub 2018 Nov 23. Review.

PMID:
30470867
4.

Long-term Adverse Outcomes of Urolithiasis.

Ferraro PM, Curhan GC.

Am J Kidney Dis. 2018 Dec;72(6):774-775. doi: 10.1053/j.ajkd.2018.07.021. No abstract available.

PMID:
30470296
5.

Changes in renal papillary density after hydration therapy in calcium stone formers.

Ferraro PM, Vittori M, Macis G, D'Addessi A, Lombardi G, Palmisano C, Gervasoni J, Primiano A, Bassi PF, Gambaro G.

BMC Urol. 2018 Nov 12;18(1):101. doi: 10.1186/s12894-018-0415-7.

6.

Recurrent kidney stones in a family with a mitochondrial disorder due to the m.3243A>G mutation.

Bargagli M, Primiano G, Primiano A, Gervasoni J, Naticchia A, Servidei S, Gambaro G, Ferraro PM.

Urolithiasis. 2018 Nov 7. doi: 10.1007/s00240-018-1087-1. [Epub ahead of print] No abstract available.

PMID:
30406307
7.

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study.

Pugliese D, Aratari A, Festa S, Ferraro PM, Monterubbianesi R, Guidi L, Scribano ML, Papi C, Armuzzi A.

Gastroenterol Res Pract. 2018 Oct 3;2018:4195968. doi: 10.1155/2018/4195968. eCollection 2018.

8.

UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis.

Placek K, Baer GM, Elman L, McCluskey L, Hennessy L, Ferraro PM, Lee EB, Lee VMY, Trojanowski JQ, Van Deerlin VM, Grossman M, Irwin DJ, McMillan CT.

Neurobiol Aging. 2019 Jan;73:190-199. doi: 10.1016/j.neurobiolaging.2018.09.031. Epub 2018 Sep 27.

PMID:
30368160
9.

Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers.

Wollin DA, Kaplan AG, Preminger GM, Ferraro PM, Nouvenne A, Tasca A, Croppi E, Gambaro G, Heilberg IP.

Asian J Urol. 2018 Oct;5(4):235-242. doi: 10.1016/j.ajur.2018.06.007. Epub 2018 Jun 26. Review.

10.

Increased β-Cell Workload Modulates Proinsulin-to-Insulin Ratio in Humans.

Mezza T, Ferraro PM, Sun VA, Moffa S, Cefalo CMA, Quero G, Cinti F, Sorice GP, Pontecorvi A, Folli F, Mari A, Alfieri S, Giaccari A.

Diabetes. 2018 Nov;67(11):2389-2396. doi: 10.2337/db18-0279. Epub 2018 Aug 21.

PMID:
30131390
11.

[Recurrent Kidney Stones in a patient with Malabsorption Syndrome].

Bargagli M, Fulignati P, D'Alonzo S, Naticchia A, Galli D, Ferraro PM.

G Ital Nefrol. 2018 Jul;35(4). pii: 2018-vol4. Italian.

PMID:
30035444
12.

Shock-wave lithotripsy or ureterorenoscopy for renal stones?

Ferraro PM, Pinto F, Gambaro G.

Clin Kidney J. 2018 Jun;11(3):362-363. doi: 10.1093/ckj/sfy025. Epub 2018 Apr 11.

13.

Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.

Ferraro PM, Ticinesi A, Meschi T, Rodgers A, Di Maio F, Fulignati P, Borghi L, Gambaro G.

J Urol. 2018 Nov;200(5):1082-1087. doi: 10.1016/j.juro.2018.06.029. Epub 2018 Jun 22.

PMID:
29940247
14.

Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index.

Santoro L, Flex A, Nesci A, Ferraro PM, De Matteis G, Di Giorgio A, Giupponi B, Saviano L, Gambaro G, Franceschi F, Gasbarrini A, Landolfi R, Santoliquido A.

Eur Rev Med Pharmacol Sci. 2018 May;22(10):3160-3165. doi: 10.26355/eurrev_201805_15076.

15.

[A young girl with recurrent calculosis and hypercalcemia].

Di Maio F, Vittori M, Bassi P, Fulignati P, D'Alonzo S, Ferraro PM.

G Ital Nefrol. 2018 May;35(3). pii: 2018-vol3. Italian.

PMID:
29786188
16.

Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Ferraro PM, Jester C, Olm CA, Placek K, Agosta F, Elman L, McCluskey L, Irwin DJ, Detre JA, Filippi M, Grossman M, McMillan CT.

Neurobiol Aging. 2018 Aug;68:85-92. doi: 10.1016/j.neurobiolaging.2018.04.008. Epub 2018 Apr 17.

PMID:
29751289
17.

Negative effect of vitamin D on kidney function: a Mendelian randomization study.

Teumer A, Gambaro G, Corre T, Bochud M, Vollenweider P, Guessous I, Kleber ME, Delgado GE, Pilz S, März W, Barnes CLK, Joshi PK, Wilson JF, de Borst MH, Navis G, van der Harst P, Heerspink HJL, Homuth G, Endlich K, Nauck M, Köttgen A, Pattaro C, Ferraro PM.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2139-2145. doi: 10.1093/ndt/gfy074.

PMID:
29718335
18.

Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity.

Nestola M, De Matthaeis N, Ferraro PM, Fuso P, Costanzi S, Zannoni GF, Pizzolante F, Vasquez Quadra S, Gambaro G, Rapaccini GL.

J Ultrasound. 2018 Jun;21(2):81-87. doi: 10.1007/s40477-018-0298-1. Epub 2018 Apr 24.

PMID:
29691759
19.

Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.

Brück K, Jager KJ, Zoccali C, Bello AK, Minutolo R, Ioannou K, Verbeke F, Völzke H, Arnlöv J, Leonardis D, Ferraro PM, Brenner H, Caplin B, Kalra PA, Wanner C, Castelao AM, Gorriz JL, Hallan S, Rothenbacher D, Gibertoni D, De Nicola L, Heinze G, Van Biesen W, Stel VS; European CKD Burden Consortium.

Kidney Int. 2018 Jun;93(6):1432-1441. doi: 10.1016/j.kint.2018.01.008. Epub 2018 Apr 12.

PMID:
29656901
20.

A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).

De Paolis E, Minucci A, De Bonis M, Scaglione GL, Gervasoni J, Primiano A, Ferraro PM, Cappellani D, Marcocci C, Gambaro G, Capoluongo E.

Clin Chim Acta. 2018 Jul;482:8-13. doi: 10.1016/j.cca.2018.03.024. Epub 2018 Mar 21.

PMID:
29574006
21.

Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus.

Spatola L, Ferraro PM, Gambaro G, Badalamenti S, Dauriz M.

Metabolism. 2018 Jun;83:225-233. doi: 10.1016/j.metabol.2018.02.008. Epub 2018 Mar 3. Review.

PMID:
29510180
22.

Chronic pain in medullary sponge kidney: a rare and never described clinical presentation.

Gambaro G, Goldfarb DS, Baccaro R, Hirsch J, Topilow N, D'Alonzo S, Gambassi G, Ferraro PM.

J Nephrol. 2018 Aug;31(4):537-542. doi: 10.1007/s40620-018-0480-8. Epub 2018 Feb 21.

PMID:
29468561
23.

Intake of Trace Metals and the Risk of Incident Kidney Stones.

Ferraro PM, Gambaro G, Curhan GC, Taylor EN.

J Urol. 2018 Jun;199(6):1534-1539. doi: 10.1016/j.juro.2018.01.077. Epub 2018 Jan 31.

PMID:
29391176
24.

A STARD-compliant prediction model for diagnosing thrombotic microangiopathies.

Ferraro PM, Lombardi G, Naticchia A, Sturniolo A, Zuppi C, De Stefano V, Bonelli P, Buonocore R, Cervellin G, Lippi G, Gambaro G.

J Nephrol. 2018 Jun;31(3):405-410. doi: 10.1007/s40620-018-0468-4. Epub 2018 Jan 20.

PMID:
29353400
25.

Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.

Seeger H, Kaelin A, Ferraro PM, Weber D, Jaeger P, Ambuehl P, Robertson WG, Unwin R, Wagner CA, Mohebbi N.

BMC Nephrol. 2017 Dec 4;18(1):349. doi: 10.1186/s12882-017-0755-7.

26.

Relative Supersaturation of 24-Hour Urine and Likelihood of Kidney Stones.

Prochaska M, Taylor E, Ferraro PM, Curhan G.

J Urol. 2018 May;199(5):1262-1266. doi: 10.1016/j.juro.2017.10.046. Epub 2017 Nov 11.

27.

TBK1 mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation.

Pozzi L, Valenza F, Mosca L, Dal Mas A, Domi T, Romano A, Tarlarini C, Falzone YM, Tremolizzo L, Sorarù G, Cerri F, Ferraro PM, Basaia S, Agosta F, Fazio R, Comola M, Comi G, Ferrari M, Quattrini A, Lunetta C, Penco S, Bonanomi D, Carrera P, Riva N.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):869-875. doi: 10.1136/jnnp-2017-316174. Epub 2017 Aug 19.

28.

Multimodal structural MRI in the diagnosis of motor neuron diseases.

Ferraro PM, Agosta F, Riva N, Copetti M, Spinelli EG, Falzone Y, Sorarù G, Comi G, Chiò A, Filippi M.

Neuroimage Clin. 2017 Aug 2;16:240-247. doi: 10.1016/j.nicl.2017.08.002. eCollection 2017.

29.

Serum Uric Acid and Risk of Kidney Stones.

Ferraro PM, Curhan GC.

Am J Kidney Dis. 2017 Aug;70(2):158-159. doi: 10.1053/j.ajkd.2017.05.004. No abstract available.

PMID:
28739125
30.

Vitamin B6 intake and the risk of incident kidney stones.

Ferraro PM, Taylor EN, Gambaro G, Curhan GC.

Urolithiasis. 2018 Jun;46(3):265-270. doi: 10.1007/s00240-017-0999-5. Epub 2017 Jul 3.

PMID:
28674784
31.

Structural and functional brain signatures of C9orf72 in motor neuron disease.

Agosta F, Ferraro PM, Riva N, Spinelli EG, Domi T, Carrera P, Copetti M, Falzone Y, Ferrari M, Lunetta C, Comi G, Falini A, Quattrini A, Filippi M.

Neurobiol Aging. 2017 Sep;57:206-219. doi: 10.1016/j.neurobiolaging.2017.05.024. Epub 2017 Jun 6.

PMID:
28666709
32.

Dietary and Lifestyle Risk Factors Associated with Incident Kidney Stones in Men and Women.

Ferraro PM, Taylor EN, Gambaro G, Curhan GC.

J Urol. 2017 Oct;198(4):858-863. doi: 10.1016/j.juro.2017.03.124. Epub 2017 Mar 30.

33.

The Risk of Chronic Kidney Disease Associated with Urolithiasis and its Urological Treatments: A Review.

Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, Mazzaferro S, D'Addessi A, Ferraro PM.

J Urol. 2017 Aug;198(2):268-273. doi: 10.1016/j.juro.2016.12.135. Epub 2017 Mar 10. Review.

PMID:
28286070
34.

Zinc as a Contributing Factor in Lithogenesis: Not Yet Ready for the Clinic.

Ferraro PM, Curhan G.

J Urol. 2017 May;197(5):1187-1188. doi: 10.1016/j.juro.2017.02.025. Epub 2017 Feb 16. No abstract available.

PMID:
28213281
35.

Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?

Johri N, Jaeger P, Ferraro PM, Shavit L, Nair D, Robertson WG, Gambaro G, Unwin RJ.

Urolithiasis. 2017 Dec;45(6):535-543. doi: 10.1007/s00240-016-0954-x. Epub 2016 Dec 16.

36.

Tubular and genetic disorders associated with kidney stones.

Mohebbi N, Ferraro PM, Gambaro G, Unwin R.

Urolithiasis. 2017 Feb;45(1):127-137. doi: 10.1007/s00240-016-0945-y. Epub 2016 Nov 28. Review.

PMID:
27896392
37.

Erratum to: A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass.

Ferraro PM, Minucci A, Primiano A, De Paolis E, Gervasoni J, Persichilli S, Naticchia A, Capoluongo E, Gambaro G.

Urolithiasis. 2017 Jun;45(3):295. doi: 10.1007/s00240-016-0940-3. No abstract available.

PMID:
27885408
38.

Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy.

Vittori M, Baroni S, Ferraro PM, Gambaro G, Morelli R, Bassi P, D'Addessi A.

Urolithiasis. 2017 Aug;45(4):347-351. doi: 10.1007/s00240-016-0932-3. Epub 2016 Oct 27.

PMID:
27787615
39.

Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.

Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group.

J Nephrol. 2016 Dec;29(6):715-734. Epub 2016 Jul 25. Review.

40.

A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass.

Ferraro PM, Minucci A, Primiano A, De Paolis E, Gervasoni J, Persichilli S, Naticchia A, Capoluongo E, Gambaro G.

Urolithiasis. 2017 Jun;45(3):291-294. doi: 10.1007/s00240-016-0923-4. Epub 2016 Sep 17. Erratum in: Urolithiasis. 2017 Jun;45(3):295.

PMID:
27639704
41.

Vitamin D Intake and the Risk of Incident Kidney Stones.

Ferraro PM, Taylor EN, Gambaro G, Curhan GC.

J Urol. 2017 Feb;197(2):405-410. doi: 10.1016/j.juro.2016.08.084. Epub 2016 Aug 18.

42.

Cognitive impairment in progressive supranuclear palsy-Richardson's syndrome is related to white matter damage.

Caso F, Agosta F, Volonté MA, Ferraro PM, Tiraboschi P, Copetti M, Valsasina P, Falautano M, Comi G, Falini A, Filippi M.

Parkinsonism Relat Disord. 2016 Oct;31:65-71. doi: 10.1016/j.parkreldis.2016.07.007. Epub 2016 Jul 18.

PMID:
27453032
43.

Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones.

Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1834-1844. doi: 10.2215/CJN.01520216. Epub 2016 Jul 21.

44.

New semiquantitative ultrasonographic score for peripheral arterial disease assessment and its association with cardiovascular risk factors.

Santoro L, Ferraro PM, Flex A, Nesci A, De Matteis G, Di Giorgio A, Zaccone V, Gambaro G, Gasbarrini A, Santoliquido A.

Hypertens Res. 2016 Dec;39(12):868-873. doi: 10.1038/hr.2016.88. Epub 2016 Jul 14.

45.

Characterization of the Protein Components of Matrix Stones Sheds Light on S100-A8 and S100-A9 Relevance in the Inflammatory Pathogenesis of These Rare Renal Calculi.

Martelli C, Marzano V, Iavarone F, Huang L, Vincenzoni F, Desiderio C, Messana I, Beltrami P, Zattoni F, Ferraro PM, Buchholz N, Locci G, Faa G, Castagnola M, Gambaro G.

J Urol. 2016 Sep;196(3):911-8. doi: 10.1016/j.juro.2016.04.064. Epub 2016 Apr 23.

PMID:
27113968
46.

Increased renal papillary density in kidney stone formers detectable by CT scan is a potential marker of stone risk, but is unrelated to underlying hypercalciuria.

Shavit L, Girfoglio D, Kirkham A, Allen D, Ferraro PM, Moochhala S, Unwin R.

Urolithiasis. 2016 Oct;44(5):471-5. doi: 10.1007/s00240-016-0873-x. Epub 2016 Mar 29.

PMID:
27023714
47.

Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature.

Ferraro PM, Curhan GC, D'Addessi A, Gambaro G.

J Nephrol. 2017 Apr;30(2):227-233. doi: 10.1007/s40620-016-0283-8. Epub 2016 Mar 11. Review.

PMID:
26969574
48.

Brain MR Imaging in Patients with Lower Motor Neuron-Predominant Disease.

Spinelli EG, Agosta F, Ferraro PM, Riva N, Lunetta C, Falzone YM, Comi G, Falini A, Filippi M.

Radiology. 2016 Aug;280(2):545-56. doi: 10.1148/radiol.2016151846. Epub 2016 Mar 9.

PMID:
26963576
49.
50.

Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review.

Brück K, Jager KJ, Dounousi E, Kainz A, Nitsch D, Ärnlöv J, Rothenbacher D, Browne G, Capuano V, Ferraro PM, Ferrieres J, Gambaro G, Guessous I, Hallan S, Kastarinen M, Navis G, Otero Gonzalez A, Palmieri L, Romundstad S, Spoto B, Stengel B, Tomson C, Tripepi G, Völzke H, Wiȩcek A, Gansevoort R, Schöttker B, Wanner C, Vinhas J, Zoccali C, Van Biesen W, Stel VS; European CKD Burden Consortium.

Nephrol Dial Transplant. 2016 Apr;31(4):680. doi: 10.1093/ndt/gfw024. Epub 2016 Feb 5. No abstract available.

PMID:
26908763

Supplemental Content

Loading ...
Support Center